Overview

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
0
Participant gender:
All
Summary
This study is designed to compare the antiviral effect of ALS-008176 compared to a placebo control in the respiratory syncytial virus challenge model.
Phase:
Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Alios Biopharma Inc.
Criteria
Inclusion Criteria:

- Age 18 to 45 years, inclusive.

- In good health with no history of major medical conditions

- A total body weight ≥ 50 kg and a body mass index (BMI) of > 18kg/m2.

Exclusion Criteria:

- Acute or chronic medical illness

- Positive for Human Immunodeficiency Virus, Hepatitis B or C

- Nose or nasopharynx abnormalities

- Abnormal lung function